Infective Endocarditis Following Transcatheter Aortic Valve Replacement and Cardiac Implantable Electronic Device
- 5 July 2021
- journal article
- letter
- Published by Elsevier BV in JACC: Cardiovascular Interventions
- Vol. 14 (13), 1503-1505
- https://doi.org/10.1016/j.jcin.2021.04.053
Abstract
No abstract availableFunding Information
- Edwards Lifesciences
- Bayer
- Boehringer Ingelheim
- Novartis
- Boston Scientific Corporation
- Abbott Laboratories
- Society for Music Theory
- AstraZeneca
- Symetis
- Medtronic
- Novo Nordisk
This publication has 5 references indexed in Scilit:
- STS-ACC TVT Registry of Transcatheter Aortic Valve ReplacementJournal of the American College of Cardiology, 2020
- Infective endocarditis in patients who have undergone transcatheter aortic valve implantation: a reviewClinical Microbiology & Infection, 2020
- Meta-Analysis Comparing the Incidence of Infective Endocarditis Following Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve ReplacementThe American Journal of Cardiology, 2019
- Incidence of infective endocarditis in patients considered at moderate riskEuropean Heart Journal, 2018
- Infective Endocarditis After Transcatheter Aortic Valve Replacement: The Worst That Can HappenJournal of the American Heart Association, 2018